Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats

British Journal of Pharmacology

Volumn 140, Issue 5, 2003, Pages 964-970

  Cano, Victoria ^a   Ezquerra, Laura ^a   Ramos, M Pilar ^a   Ruiz Gayo, Mariano ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

2 deoxyglucose; c Fos; Cholecystokinin; Fasting; Feeding; Hypothalamic pituitary adrenal axis; Hypothalamus; Paraventricular nucleus

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEOXYGLUCOSE; LINTITRIPT; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FOOD DEPRIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THALAMUS MIDLINE NUCLEUS;

ANIMALS; CHOLECYSTOKININ; FOOD DEPRIVATION; GENES, FOS; INDOLEACETIC ACIDS; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, WISTAR; RECEPTORS, CHOLECYSTOKININ; THIAZOLES;

EID: 0344873143     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705513     Document Type: Article

References (53)

1. ADACHI, A., KOBASHI, M. & FUNAHASHI, M. (1995). Glucose-responsive neurons in the brainstem. Obes. Res., 3, 735S-740S.
2. AKANA, S.F., STRACK, A.M., HANSON, E.S. & DALLMAN, M.F. (1994). Regulation of activity in the hypothalamo-pituitary-adrenal axis is integral to a larger hypothalamic system that determines caloric flow. Endocrinology, 135, 1125-1134.
3. BARBER, W.D., YUAN, C.S. & BURKS, T.F. (1990). Local effects of CCK-8 on gastric vagally-evoked responses in nucleus tractus solitarius. FASEB J., 4, A979.
4. BARHAM, D. & TRINDER, P. (1972). An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst, 97, 142-145.
5. BAXTER, J.D. & FORSHAM, P.H. (1972). Tissue effects of glucocorticoids. Am. J. Med., 52, 573-579.
6. BRANCHEREAU, P., BOHME, G.A., CHAMPAGNAT, J., MORIN-SURUN, M.P., DURIEUX, C., BLANCHARD, J.C. & DENAVIT-SÁUBIE, M. (1992). Cholecystokinin-A and cholecystokinin-B receptors in neurons of the brainstem solitary complex of the rat: pharmacological identification. J. Pharmacol. Exp. Ther., 260, 1433-1440.
7. BRISKI, K.P. & BRANDT, J.A. (2000). Oxytocin and vasopressin neurones in principal and accessory hypothalamic magnocellular structures express Fos-immunoreactivity in response to acute glucose deprivation. J. Neuroendocrinol., 12, 409-414.
8. BRISKI, K.P. & MARSHALL, E.S. (2000). Caudal brainstem Fos expression is restricted to periventricular catecholamine neuron-containing loci following intraventricular administration of 2-deoxy-D-glucose. Exp. Brain Res., 133, 547-551.
9. BROBERGER, C., HOLMBER, G.K., KUHAR, M.J. & HÖKFELT, T. (1999). Cocaine-and amphetamine-regulated transcript in the rat vagus nerve: a putative mediator of cholecystokinin-induced satiety. Proc. Natl. Acad. Sci. U.S.A., 96, 13506-13511.
10. CHANG, R.S., CHEN, T.B., BOCK, M.G., FREIDINGER, R.M., CHEN, R., ROSEGAY, A. & LOTTI, V.J. (1989). Characterization of the binding of [3H]-L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radio-ligand. Mol. Pharmacol., 35, 803-808.
11. CORP, E.S., MCQUADE, J., MORAN, T.H. & SMITH, G.P. (1993). Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res., 623, 161-166.
12. CRAWLEY, J.N. & CORWIN, R.L. (1994). Biological actions of cholecystokinin. Peptides, 15, 731-755.
13. CRAWLEY, J.N., HAYS, S.E. & PAUL, S.M. (1981). Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors. Eur. J. Pharmacol., 73, 379-380.
14. DALLMAN, M.F., AKANA, S.F., BHATNAGAR, S., BELL, M.E., CHOI, S.J., CHU, A., HORSLEY, C., LEVIN, N., MEIJER, O., SORIANO, L., STRACK, A.M. & VIAU, V. (1999). Starvation: early signals, sensors, and sequelae. Endocrinology, 140, 4015-4023.
15. DAY, H.E., MCKNIGHT, A.T., POAT, J.A. & HUGHES, J. (1994). Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology, 33, 719-727.
16. DOURISH, C.T., RYCROFT, W. & IVERSEN, S.D. (1989). Postponement of satiety by blockade of cholecystokinin (CCK-B) receptors. Science, 245, 1509-1511.
17. HAUGER, R.L. & DAUTZENBERG, F.M. (2000). Neuroendocrine correlates of stress, behaviour, and biological processes. Regulation of the stress response by corticotropin-releasing factor receptors. In: Neuroendocrinology in Physiology and Medicine, ed. Conn, P.M. & Freeman, M.E. pp. 261-286. Totowa: Humana Press.
18. HERMAN, J.P., TASKER, J.G., ZIEGLER, D.R. & CULLINAN, W.E. (2002). Local circuit regulation of paraventricular nucleus stress intgration: glutamate-GABA connections. Pharmacol. Biochem. Behav., 71, 457-468.
19. HERNANDO, F., FUENTES, J.A., ROQUES, B. & RUIZ-GAYO, M. (1994). The CCK-B receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swimming test in mice. Eur. J. Pharmacol., 261, 257-263.
20. HERNANDO, F., FUENTES, J.A. & RUIZ-GAYO, M. (1996). Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide. Br. J. Pharmacol., 118, 400-406.
21. HINKS, G.L., POAT, J.A. & HUGUES, J. (1995). Changes in hypothalamic cholecystokinin A and cholecystokinin B receptor subtypes and associated neuropeptide expression in response to salt-stress in the rat and mouse. Neuroscience, 68, 765-781.
22. HONDA, T., WADA, E., BATTEY, J.F. & WANK, S.A. (1993). Differential gene expression of CCK-A and CCK-B receptors in the rat brain. Mol. Cell. Neurosci., 4, 143-154.
23. JACOBSON, L. & SAPOLSKY, R. (1991). The role of the hipp'ocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocrine Rev., 12, 118-134.
24. KALRA, S.P., DUBE, M.G., PU, S., XU, B., HORVATH, T.L. & KALRA, P.S. (1999). Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Rev., 20, 68-100.
25. KAMILARIS, T.C., JOHNSON, E.O., CALOGERO, A.E., KALOGERAS, K.T., BERNARDINI, R., CHROUSOS, G.P. & GOLD, P.W. (1992). Cholecystokinin- octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone. Endocrinology, 130, 1764-1774.
26. LAUGERO, K.D., BELL, M.E., BHATNAGAR, S., SORIANO, L. & DALLMAN, M.F. (2001). Sucrose ingestion normalizes central expression of corticotropin- releasing-factor messenger ribonucleic acid and energy balance in adrenolectomized rats: a glucocorticoid-metabolic brain axis? Endocrinology, 142, 2796-2804.
27. LINDEN, A. (1989). Role of cholecystokinin in feeding and lactation. Acta Physiol. Scand., 585, 1-49.
28. LINDEN, A. & SÖDERSTEN, P. (1990). Relationship between the concentration of cholecystokinin-like immunoreactivity in plasma and food intake in male rats. Physiol. Behav., 48, 859-863.
29. MERCER, L.D. (2000). Immunolocalization of cholecystokinin receptors. M.Sc. Thesis. Monash University, Melbourne, Australia.
30. A receptor. Neurosci. Lett., 225, 97-100.
31. MERCER, L.D., LE, V.Q., NUNAN, J., JONES, N.M. & BEART, P.M. (2000). Direct visualization of cholecystokinin subtype 2 receptors in rat central nervous system using antipeptide antibodies. Neurosci. Lett., 293, 167-170.
32. NIIMI, M., SATO, M., TAMAKI, M., WADA, Y., TAKAHARA, J. & KAWANISHI, K. (1995). Induction of Fos protein in the rat hypothalamus elicited by insulin-induced hypoglycemia. Neurosci. Res., 23, 361-364.
33. NOBLE, F., WANK, S.A., CRAWLEY, J.N., BRADWEJN, J., SEROOGY, K.B., HAMON, M. & ROQUES, B.P. (1999). International Union of Pharmacology XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev., 54, 745-781.
34. OOMURA, Y., ONO, T., OOYAMA, H. & WAYNER, M.J. (1969). Glucose and osmosensitive neurons of rat hypothalamus. Nature, 222, 282-284.
35. O'SHEA, R.D. & GUNDLACH, A.L. (1993). Regulation of cholecystokinin receptors in the hypothalamus of the rat: reciprocal changes in magnocellular nuclei induced by food deprivation and dehydration. J. Neuroendocrinol., 5, 697-704.
36. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
37. PONCELET, M., ARNONE, M., HEAULME, M., GONALONS, N., GUEDET, C., SANTUCCI, V., THURNEYSSEN, O., KEANO, P., GULLY, D., LE FUR, G. & SOUBRIÉ, P. (1993). Neurobehavioral effects of SR-27,897, a selective cholecystokinin type A (CCK-A) receptor antagonist. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 102-107.
38. RAYBOULD, H.E., GAYTON, R.J. & DOCKRAY, G.J. (1988). Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat. J. Neurosci., 8, 3018-3024.
39. REIDELBERGER, R.D. (1992). Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats. Am. J. Physiol., 263, R1354-R1358.
40. RUIZ-GAYO, M., GARRIDO, M.M. & FUENTES, J.A. (2000). Inhibition of the hypothalamic-pituitary-adrenal axis in food-deprived rats by a CCK-A receptor antagonist. Br. J. Pharmacol., 129, 839-842.
41. SAWCHENKO, P.E. & SWANSON, L.W. (1983). Organization of the forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J. Comp. Neurol., 218, 121-144.
42. SCHICK, R.R., HARTY, G.J., YAKSH, T.L. & GO, V.L. (1990). Sites in the brain at which cholecystokinin octapeptide (CCK-8) acts to suppress feeding in rats: a mapping study. Neuropharmacology, 29, 109-118.
43. SCHIFFMANN, S.N. & VANDERHAEGHEN, J.J. (1991). Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system. J. Comp. Neurol., 304, 219-233.
44. SCHWARTZ, M.W., SEELEY, R.L., CAMPFIELD, L.A., BURN, P. & BASKIN, D.G. (1996). Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest., 98, 1101-1106.
45. SINGH, L., LEWIS, A.S., FIELD, M.J., HUGUES, J. & WOODRUFF, G.N. (1991). Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc. Natl. Acad. Sci. U.S.A., 88, 1130-1133.
46. SPANSWICK, D., SMITH, M.A., GROPPI, V.E., LOGAN, S.D. & ASHFORD, M.L.J. (1997). Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature, 390, 521-525.
47. + channels in hypothalamic neurons of lean, but not obese rats. Nat. Neurosci., 3, 757-758.
48. SWANSON, L.W. & SAWCHENKO, P.E. (1983). Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci., 6, 269-324.
49. THOMPSON, R.H. & SWANSON, L.W. (2003). Structural organization of a hypothalamic visceromotor pattern generator network. Brain Res. Rev., 41, 153-202.
50. TIMOFEEVA, E. & RICHARD, D. (1997). Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats. Neuroendocrinology, 66, 327-340.
51. VASAR, E., LANG, A., HARRO, J., BOURIN, M. & BRADWEJN, J. (1994). Evidence for potentiation of the effect of cholecystokinin octapeptide in the elevated plus-maze. Neuropharmacology, 33, 729-735.
52. VANDERHAEGHEN, J.J., LOTSTRA, F., DE MEY, J. & GILLES, C. (1980). Immunohistochemical localization of cholecystokinin-and gastrin-like peptides in the brain and hypophysis of the rat. Proc. Natl. Acad. Sci. U.S.A., 77, 1190-1194.
53. YUHAN, C.S., ATTELE, A.S., DEY, L. & XIE, J.T. (2000). Gastric effects of cholecystokinin and its interaction with leptin on brainstem neuronal activity in neonatal rats. J. Pharmacol. Exp. Therap., 295, 177-182.